| Daniel M Skotte Do Pc | |
|
57056 Beaver Dr Sunriver OR 97707-0572 | |
| (541) 593-5400 | |
| (541) 593-4076 |
| Full Name | Daniel M Skotte Do Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 57056 Beaver Dr, Sunriver, Oregon |
| Authorized Official Name and Position | Daniel M Skotte (OWNER) |
| Authorized Official Contact | 5415935400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel M Skotte Do Pc Po Box 3572 Sunriver OR 97707-0572 Ph: (541) 593-5400 | Daniel M Skotte Do Pc 57056 Beaver Dr Sunriver OR 97707-0572 Ph: (541) 593-5400 |
| NPI Number | 1003135112 |
|---|---|
| Provider Enumeration Date | 05/28/2010 |
| Last Update Date | 05/28/2010 |
| Medicare PECOS PAC ID | 8820127764 |
|---|---|
| Medicare Enrollment ID | O20100602000375 |
News Archive
For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).
New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.
Engineers from Michigan State University have secured $3.4 million in grants to develop diamond implants that could let doctors diagnose and treat Parkinson's disease earlier.
Ascendx Spine, which recently received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF), today announced an agreement with Switzerland-based anwerina AG to distribute the Ascendx Spine products in Austria, Germany and Switzerland.
Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries, according to new findings by Yale School of Medicine researchers.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003135112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 13485 (Oregon) | Primary |
| Provider Name | Daniel Skotte |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316908205 PECOS PAC ID: 7113056060 Enrollment ID: I20100603000764 |
News Archive
For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).
New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.
Engineers from Michigan State University have secured $3.4 million in grants to develop diamond implants that could let doctors diagnose and treat Parkinson's disease earlier.
Ascendx Spine, which recently received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF), today announced an agreement with Switzerland-based anwerina AG to distribute the Ascendx Spine products in Austria, Germany and Switzerland.
Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries, according to new findings by Yale School of Medicine researchers.
› Verified 2 days ago
News Archive
For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).
New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.
Engineers from Michigan State University have secured $3.4 million in grants to develop diamond implants that could let doctors diagnose and treat Parkinson's disease earlier.
Ascendx Spine, which recently received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF), today announced an agreement with Switzerland-based anwerina AG to distribute the Ascendx Spine products in Austria, Germany and Switzerland.
Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries, according to new findings by Yale School of Medicine researchers.
› Verified 2 days ago